April 14, 2016 / 4:56 AM / 2 years ago

BRIEF-S&P says Valeant corporate credit rating lowered to 'B' from 'B+'

April 14 (Reuters) - S&P:

* Valeant Pharmaceuticals International Inc. corporate credit rating lowered to ‘B’ from ‘B+’ and placed on watch developing

* Lowered rating on valeant pharmaceuticals international inc secured debt to ‘BB-‘ from ‘BB’

* Downgrade reflects an escalation in the risk of a near-term default if Valeant is unable to file its 10-K

* Downgrade reflects escalation in the risk of a near-term default if Valeant unable to negotiate consent with bondholders over the next 2 months

* Continue to believe value of Valeant’s assets likely exceeds total debt outstanding and view that as supportive of creditworthiness

* Believe Ackman,Pershing Square’s interests, predominantly aligned with shareholders, may be contributing to Valeant’s financial policies

* Believe there is greater risk that Valeant may be unsuccessful in consent/waiver with bondholders than it was with bank debt Source text - (bit.ly/1VqXsdc) (Bengaluru Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below